Vontobel Holding’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
3,864
-1,478
-28% -$306K ﹤0.01% 905
2026
Q1
$1.2M Sell
5,342
-29
-0.5% -$7.23K ﹤0.01% 620
2025
Q4
$1.29M Sell
5,371
-251
-4% -$64.2K ﹤0.01% 689
2025
Q3
$1.54M Sell
5,622
-787
-12% -$215K ﹤0.01% 616
2025
Q2
$1.65M Buy
6,409
+1,266
+25% +$302K 0.01% 557
2025
Q1
$1.15M Buy
5,143
+1,707
+50% +$399K ﹤0.01% 547
2024
Q4
$786K Sell
3,436
-226
-6% -$54.4K ﹤0.01% 661
2024
Q3
$894K Buy
3,662
+288
+9% +$64.4K ﹤0.01% 618
2024
Q2
$646K Sell
3,374
-10,460
-76% -$2.12M ﹤0.01% 700
2024
Q1
$2.74M Sell
13,834
-6,173
-31% -$1.13M 0.02% 392
2023
Q4
$3.44M Buy
20,007
+2,250
+13% +$346K 0.03% 354
2023
Q3
$2.63M Buy
17,757
+1,126
+7% +$204K 0.02% 382
2023
Q2
$3.63M Buy
16,631
+1,114
+7% +$248K 0.03% 352
2023
Q1
$3.4M Sell
15,517
-1,637
-10% -$355K 0.03% 345
2022
Q4
$3.53M Buy
17,154
+4,227
+33% +$929K 0.04% 339
2022
Q3
$2.82M Buy
12,927
+1,642
+15% +$374K 0.03% 346
2022
Q2
$2.4M Buy
11,285
+3,173
+39% +$675K 0.03% 363
2022
Q1
$2.02M Buy
8,112
+1,025
+14% +$248K 0.02% 425
2021
Q4
$1.86M Buy
7,087
+840
+13% +$218K 0.02% 458
2021
Q3
$1.65M Sell
6,247
-2,233
-26% -$611K 0.01% 486
2021
Q2
$2.09M Sell
8,480
-1,669
-16% -$351K 0.02% 423
2021
Q1
$1.97M Buy
10,149
+1,985
+24% +$398K 0.01% 403
2020
Q4
$1.65M Buy
+8,164
New +$1.63M 0.01% 443

Other funds holding RMD

Vontobel Holding's RMD Position: Q2 2026 in Review

Vontobel Holding reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $306K and leaving 3,864 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Vontobel Holding first reported a position in RMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.63M in Q2 2023. 448 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vontobel Holding held 3,864 shares of ResMed worth $753K as of Q2 2026.
  • Vontobel Holding sold 1,478 ResMed shares in Q2 2026, an estimated $306K.
  • ResMed made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #905 holding.
  • Vontobel Holding first reported a position in ResMed in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's ResMed position peaked at $3.63M in Q2 2023.
  • 448 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.